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Abstract. Post-translational modification of lysine residues by NƐ-acylation is an
important regulator of protein function. Many large-scale protein acylation studies
have assessed relative changes of lysine acylation sites after antibody enrichment
using mass spectrometry-based proteomics. Although relative acylation fold-
changes are important, this does not reveal site occupancy, or stoichiometry, of
individual modification sites, which is critical to understand functional consequences.
Recently, methods for determining lysine acetylation stoichiometry have been pro-
posed based on ratiometric analysis of endogenous levels to those introduced after
quantitative per-acetylation of proteins using stable isotope-labeled acetic anhydride.
However, in our hands, we find that these methods can overestimate acetylation
stoichiometries because of signal interferences when endogenous levels of acylation are very low, which is
especially problematic when usingMS1 scans for quantification. In this study, we sought to improve the accuracy
of determining acylation stoichiometry using data-independent acquisition (DIA). Specifically, we use SWATH
acquisition to comprehensively collect both precursor and fragment ion intensity data. The use of fragment ions
for stoichiometry quantification not only reduces interferences but also allows for determination of site-level
stoichiometry from peptides with multiple lysine residues. We also demonstrate the novel extension of this
method to measurements of succinylation stoichiometry using deuterium-labeled succinic anhydride. Proof of
principle SWATH acquisition studies were first performed using bovine serum albumin for both acetylation and
succinylation occupancymeasurements, followed by the analysis of more complex samples ofE. coli cell lysates.
Although overall site occupancy was low (<1%), some proteins contained lysines with relatively high acetylation
occupancy.
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Introduction
Post-translational modification of lysine residues by N -acetylation can modulate protein activities, conformation,
and protein–protein interactions [1, 2]. Lysine acetylation and
other acylations are thought to play key roles in metabolism
and cell signaling [3]. In eukaryotes, the acetylation and
deacetylation of lysine residues in histones has long been
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recognized as a mechanism to regulate their binding to DNA
[4, 5]. Recently, other proteins have been found to undergo
acetylation, with a large number localized to the mitochondria
[6, 7]. In addition to lysine acetylation, other types of lysine
acylationmodifications, including succinylation, malonylation,
and glutarylation, are highly prevalent in mitochondrial pro-
teins isolated from various mouse tissues and human cell lines
[8–14]. Other studies have also found acylation modifications
in bacteria, and proteins involved in central metabolism, trans-
lation, and transcription are heavily modified in E. coli [15–
24]. For example, Colak et al. [21] identified 2803 lysine
acetylation sites in 782 proteins and 2580 lysine succinylation
sites in 670 proteins in wild-type E. coli strains.
In mitochondria, no lysine acyltransferase has been identi-
fied, leading to speculation that mitochondrial acylation may
result from the nonenzymatic reaction of lysine with reactive
acyl-CoAs [25, 26]. The removal of these modifications is
regulated by mitochondrial NAD+-dependent deacylases,
SIRT3 and SIRT5 [27–29]; SIRT3 is highly expressed in
mitochondria-rich tissues, and expression in liver, heart, and
skeletal muscle is differentially regulated in response to chang-
es in nutrient availability [30, 31]. Several mass spectrometric
studies have investigated SIRT3 knockout mice, which feature
hyperacetylation of mitochondrial proteins [8, 9], and similar
studies of SIRT5 knockout mice identified SIRT5-regulated
sites of succinyl- and malonyl-protein modifications [10–13].
SIRT5 was also described as a de-glutarylase [14]. In bacteria,
effects of lysine acetylation on central metabolism were first
described for E. coli [32, 33]. Since then, several reports have
described extensive remodeling of the E. coli acetylome in
mutant strains lacking the sirtuin homolog CobB, [15–17, 21,
22, 34] or in response to certain nutrient conditions [22–24].
Recently, Svinkina et al. published an in-depth mass spectro-
metric study with an optimized acetylation enrichment
workflow using a new monoclonal antibody mixture [35].
Although many studies have clearly shown that lysine
acyl modifications undergo large fold-changes under differ-
ent conditions, precise measures of acylation site occupancy,
or stoichiometry, are scarce. Some investigators have used
methods originally developed for estimating occupancy of
protein phosphorylation [36] in stable-isotope labeling with
amino acids in cell culture (SILAC) experiments by com-
paring peptide ion measurements obtained after affinity en-
richment to their unmodified counterparts observed prior to
enrichment [37]. However, these indirect methods can be
problematic as they rely on several assumptions, for exam-
ple, that the modified and unmodified peptide show similar
ionization efficiency, which is usually not the case. Addi-
tionally, this method assumes that measured peptides are
only modified by the modification of interest, which may
be true in the case of phosphorylation but is often not true for
lysine acylation; many distinct lysine modifications occur at
the same position assessments. Using this strategy, Weinert
et al. reported very low acetylation occupancy for SIRT3-
targeted sites from mouse liver, where the vast majority of
sites (97%) were <1% acetylated [38].
Recently, two groups have reported more direct methods for
determining lysine acetylation site occupancies that determine
the ratio of abundance of endogenous Blight^ acetyl groups to
stable isotope-labeled Bheavy^ acetyl groups, the latter being
generated by quantitative per-acetylation of unmodified lysines
in vitro. For example, Nakayasu et al. labeled peptides
with 13C2-acetic anhydride after Arg-C digestion followed by
MS2-based quantification of acetyl lysine immonium ions
[39], while Baeza et al. labeled intact proteins with acetic
anhydride-d6 followed by trypsin digestion and precursor ion
quantification of acetyl lysine-containing peptides pairs [15].
Using this approach, Baeza et al. made a comprehensive as-
sessment of lysine acetylation stoichiometries in 899 E. coli
proteins where lysine acetyl occupancy ranged from less than
1% to 98%. Stoichiometry was determined as 0–10% for
~2500 peptides, 10–20% for ~500 peptides, 20–30% for ~60
peptides, and greater than 30% for ~70 peptides. However,
using this strategy, we found that stoichiometry measurements
based on isotope ratios obtained fromMS1 spectra are prone to
overestimation because of signal interferences, particularly as
most acetylation occupancies are very low (<1%). For exam-
ple, accurate measurement of 1% acetylation occupancy re-
quires an interference-free peptide signal over at least two
orders of magnitude. Therefore, these experiments require both
the determination of accurate isotopic abundances over a large
dynamic range, and the ability to remove signal interferences
that may otherwise distort these measurements. This is in
contrast with a conceptually similar, commonly-used quantifi-
cation method, SILAC, where the expected (null hypothesis)
ratio is 1:1, and ratios greater than 10-fold are uncommon.
Quite recently, Zhou et al. [40] described an approach to
assess lysine acetylation site stoichiometries that also employed
quantitative acetylation of all free lysines in proteins with stable
isotope labeling coupled to analysis using MS2 fragment ion
intensities. While measuring ion intensity differences of MS2
ions likely improves overall accuracy by reducing interfer-
ences, quantification from data-dependent acquisition (DDA)
poses other problems. For example, using DDA-generatedMS/
MS spectra for quantification can suffer from stochastic sam-
pling deficiencies, as some precursors may never be selected
for MS/MS due to their low abundances. Another issue is that
light and heavy peptide precursors may be selected for MS/MS
at different points during peak elution, resulting in distorted
ratios, especially with deuterated species that can elute slightly
before their protonated counterparts [41].
To address the challenges inherent in accurate quantification
of lysine acylation stoichiometry, we have developed a method
that applies a variation of the stable isotope labeling method
from Baeza et al. [15], followed by SWATH acquisition that
collects both precursor and multiple fragment ion abundances
[42]. We first benchmarked this new acylation occupancy
workflow with experiments using (acetylated) bovine serum
albumin (BSA), and then we investigated protein lysates from
E. coli under different growth conditions where we had previ-
ously observed large fold-changes in acetylation levels [23],
but where data on the site occupancy of these changes was not
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known. We also present a tractable method for data analysis
using a combination of Skyline and custom scripts written in-
house. The combination of our SWATH fragment ion quanti-
fication and our custom software allow us to determine site-
specific acylation stoichiometry from peptides containing mul-
tiple lysines. We extended the method to allow determination
of lysine succinylation stoichiometry. Our results indicate that
using SWATH fragment ion quantification improves accuracy
and precision compared to results from only precursor quanti-
fication. We find the majority of both lysine acetylation and
succinylation site occupancies in E. coli are relatively low
(<1%–5%), but some sites have higher stoichiometry (>5%).
Experimental
Chemicals
Acetonitrile and water were obtained from Burdick and Jackson
(Muskegon, MI, USA). Reagents for protein chemistry includ-
ing iodoacetamide, dithiothreitol (DTT), ammonium bicarbon-
ate, formic acid (FA), urea, succinic anhydride, acetic
anhydride-d6 (>99% deuterium atom enrichment), and succinic
anhydride-2,2′,3,3′-d4 (>98% deuterium atom enrichment) were
purchased from SigmaAldrich (St. Louis, MO, USA). BSA and
acetylated BSA were purchased from Pierce (Rockford, IL,
USA). Sequencing grade Glu-C endoproteinase was purchased
from Roche (Indianapolis, IN, USA). HLB Oasis SPE car-
tridges were purchased from Waters (Milford, MA, USA).
K-acyl Enrichment from Digested E. coli Lysate
Wild-type E. coli K-12 strain BW25113 was grown in TB7
(which contains 1% wt/vol tryptone buffered at pH 7.0 with
100 mM potassium phosphate) either supplemented or not with
0.4% glucose [23]; alternatively, for some experiments, TB7
was supplemented with 33 mM succinic acid. Cell pellets were
collected and lysed as previously described by Schilling et al.
[23]. Briefly, proteins were resuspended in 6 M urea, 100 mM
Tris, 75 mM NaCl containing the deacetylase inhibitors 1 mM
tricostatin A, and 3 mM nicotinamide. Typically 1.5 mg of
protein lysate was reduced with 20 mM DTT (37 °C for 1 h),
and alkylated with 40 mM iodoacetamide (30 min at RT in the
dark). Samples were diluted 10-fold with 100 mM Tris pH 8.0
and incubated overnight at 37 °C with sequencing grade Glu-C
(Roche) added at a 1:50 enzyme:substrate ratio (wt:wt). Sam-
ples were acidified with formic acid and desalted using HLB
Oasis SPE cartridges (Waters) [43]. Proteolytic peptides were
eluted, concentrated to near dryness, and resuspended in NET
buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM
EDTA). Proteolytic acetyllysine-containing peptides were
affinity-purified using the agarose conjugated polyclonal anti-
acetyllysine antibody from ImmuneChem (ICP0380-100) that
was prewashed and incubated with 1 mg digested E. coli
protein lysate (in NET buffer) overnight (4 °C) at a 1:25
antibody:peptide ratio (wt:wt) as previously described [23].
Prior to mass spectrometric analysis, the acetyllysine peptide
enrichment fractions were concentrated and desalted using
C-18 zip-tips (Millipore, Billerica, MA, USA). Similarly, K-
succinyl peptides were enriched (for identification purposes)
from 1 mg of Glu-C-digested E. coli protein lysate using the
PTMScan agarose conjugated anti-succinyllysine antibody
from CST, a 7 monoclonal Ab mixture, according to the
manufacturer’s protocol except that 1/4 of an aliquot (20 μL
slurry) of antibody-bead conjugate was used per 1 mg of
digested E. coli protein lysate. Prior to mass spectrometric
analysis, the enriched peptides were concentrated and desalted
using StageTips made in house with three disks of Empore C18
material (3 M, Minneapolis, MN, USA). Acetylated and
succinylated peptides and proteins that were identified by mass
spectrometric analysis from these enrichment protocols are
listed in Supplementary Table S1a–c.
Chemical Treatments to Quantitatively Acetylate
and Succinylate Proteins—Acylation Stoichiometry
BSA Per-Acetylation: 100 μg of BSA protein was diluted to
1 μg/uL using ammonium bicarbonate solution (8 M urea,
200 mM ammonium bicarbonate pH 8). Dithiothreitol was
added to a final concentration of 20 mM and incubated at 37
°C for 30 min. Iodoacetamide was added to a final concentration
of 40 mM and incubated in the dark at room temperature for
30 min. Chemical per-acetylation was performed using an ad-
justed protocol from Baeza et al. [15] by adding 60 μmol of
acetic anhydride-d6 (Sigma Aldrich) to the sample and incubat-
ing in a Thermomixer at 4 °C for 20 min. The chemical acety-
lation process was repeated twice more. Ammonium hydroxide
was added between each per-acetylation reaction to increase the
pH to ~8, and 5 μL of 50% hydroxylamine was added after the
final reaction to revert O-acetylation side reactions (note: the
labeling reaction can also be carried out using 200 mM
triethanolamine bicarbonate, TEAB, instead of ammonium bi-
carbonate). The urea concentration was diluted to 0.8 M using
25 mM ammonium bicarbonate and the protease Glu-C was
added at a 1:50 ratio (wt:wt) and incubated overnight at 37 °C.
Samples were then acidified by the addition of formic acid to 1%
by volume and desalted using Oasis HLB extraction cartridges.
The eluate was dried in a Speed-Vac and resuspended in 0.1%
formic acid with 2% ACN. For per-acetylation of the E. coli
lysate, 1 mg protein lysate was reacted with 60 μmol acetic
anhydride-d6 per each of the three subsequent per-acylation
incubations. Per-succinylation was performed using the same
protocols as for the per-acetylation experiments described above
(for BSA experiments and for E. coli lysate experiments, respec-
tively). The succinic anhydride-d4 powder was dissolved in dry
DMSO prior to the reaction and used at the same molarity as
described above for the acetic anhydride-d6.
Offline Peptide Fractionation by Basic-pH Reversed
Phase HPLC
Per-acylated and Glu-C digested proteins from whole E. coli
lysates were separated by a Waters 1525 binary HPLC pump
system including a Waters 2487 UV detector. The high-pH
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reversed phase peptide separation was performed using an
Agilent Zorbax 300Extend C18 column (4.6 mm × 250 mm,
5 μm particle size; Agilent, Santa Clara, CA, USA). Peptides
were separated at a flowrate of 0.7 mL/min using the following
gradient: 100% A to 92% A over 7.3 min, 92% A to 73% A
over 38 min, 73% A to 69% A over 4 min, 69% A to 61% A
over 16 min, 61% A to 40% A over 7 min, 40% A to 10% A
over 7.73 min, constant 10% A from 80 to 85 min, 10% A to
100% from 85 to 86 min, and finally re-equilibrated in 100%A
for 24 min. Buffer A was 10 mM ammonium formate in water,
and buffer B was 10 mM ammonium formate in 90%ACN and
10% water. The pH of both mobile phases adjusted to 10 with
neat ammonia. Fractions were automatically collected and
every eighth fraction was pooled, resulting in eight final frac-
tions as described previously [35, 44].
Mass Spectrometry
Samples were analyzed by reverse-phase HPLC-ESI-MS/MS
using the Eksigent Ultra Plus nano-LC 2D HPLC system
(Dublin, CA, USA) combined with a cHiPLC System, which
was directly connected to a quadrupole time-of-flight SCIEX
TripleTOF 5600 or a TripleTOF 6600 mass spectrometer
(SCIEX, Redwood City, CA, USA). Typically, mass resolution
in precursor scans was ~35,000 (TripleTOF 5600) or 45,000
(TripleTOF 6600), whereas fragment ion resolution was
~15,000 in ‘high sensitivity’ product ion scan mode. After
injection, peptide mixtures were transferred onto a C18 pre-
column chip (200 μm × 6 mm ChromXP C18-CL chip, 3 μm,
300 Å, SCIEX) and washed at 2 μL/min for 10 min with the
loading solvent (H2O/0.1% formic acid) for desalting. Subse-
quently, peptides were transferred to the 75 μm × 15 cm
ChromXP C18-CL chip, 3 μm, 300 Å, (SCIEX), and eluted
at a flow rate of 300 nL/min using a 2 h gradient using aqueous
and acetonitrile solvent buffers.
Some initial data-dependent acquisitions (DDA) were car-
ried out to obtain MS/MS spectra for the 30 most abundant
precursor ions (100 ms per MS/MS) following each survey
MS1 scan (250 ms), yielding a total cycle time of 3.3 s as
previously described [22, 45]. For collision induced dissocia-
tion tandem mass spectrometry (CID-MS/MS), the mass win-
dow for precursor ion selection of the quadrupole mass ana-
lyzer was set to ±1m/z using the Analyst 1.7 (build 96) soft-
ware. All stoichiometry study samples were analyzed by data-
independent acquisitions (DIA), or specifically variable win-
dow SWATH acquisitions. In these SWATH acquisitions,
instead of the Q1 quadrupole transmitting a narrow mass range
through to the collision cell, windows of variable width (5 to
90m/z) are passed in incremental steps over the full mass range
(m/z 400–1250). The cycle time of 3.2 s includes a 250 ms
precursor ion scan followed by 45 ms accumulation time for
each of the 64 SWATH segments. The variable windows were
determined according to the complexity of the typical MS1 ion
current observed within a certain m/z range using a SCIEX
‘variable window calculator’ algorithm (i.e., more narrow win-
dows were chosen in ‘busy’ m/z ranges, wide windows in m/z
ranges with few eluting precursor ions). In addition, selected
samples were acquired in parallel reaction monitoring (PRM)
mode, monitoring light and heavy pairs of specific peptides as
previously described by Schilling et al. [46].
Data Processing and Bioinformatics
Mass spectrometric wiff files were first converted to mzML
using the SCIEX data converter version 1.3, and subsequently
mzML files were converted to mzXML files using
ProteoWizard version 3.0.8851. The DIA-Umpire [47] signal
extraction module was used to process SWATH acquisitions,
which detects correlated precursor and fragment ion features
and assembles them into pseudo-tandemMS/MS spectra stored
in mgf files (for details on settings and parameters see Supple-
mentary Table S2). These pseudoMS/MS spectra derived from
all SWATH acquisitions were then searched using the database
search engine Mascot [48] server version 2.3.02. In addition,
DIA-Umpire-derived mgf files containing pseudo MS/MS
spectra were searched with MSGF+ [49], refined with
PeptideProphet [50], and combined with iProphet [51]. For
the database searches, enzymatic cleavage sites were defined
at Glu (E) and Asp (D), and fixed modifications were set as
carbamidomethylation for cysteine residues. Variable modifi-
cations were defined for lysine residues as light and heavy
acetyl for acetylation occupancy experiments and as light and
heavy succinyl for succinylation occupancy experiments. False
discovery rates (FDR) were required to be <0.01. The search
engine results were subsequently used in Skyline to build
spectral libraries for SWATH data processing in Skyline.
SWATH acquisitions were quantitatively processed using
Skyline 3.5 [52], an open source software project (http://
proteome.gs.washington.edu/software/skyline). Quantitative
MS1 analysis (from SWATH acquisitions) was based on
extracted ion chromatograms (XICs) for the top three resulting
precursor ion peak areas (e.g., M, M + 1, and M + 2 [42, 45].
Final quantitative comparisons were typically based on only
the highest ranked precursor ion. Quantitative SWATH MS2
data analysis was based on extracted ion chromatograms
(XICs) of up to 10 of the most abundant fragment ions in the
identified spectra, but in contrast to MS1 quantification, only
ions containing the modified lysine of interest were used for
quantification, as those can be used to differentiate between the
light and heavy acylated peptide forms. Occupancy measure-
ments were computed from light (L) and heavy (H) peak areas
as L/(L + H).
For peptides containing only one lysine, Python (version
2.7.10) scripts written in-house were used to determine the
differentiating fragment ions and compute the stoichiometry
from custom Skyline reports. To enable quantification of pep-
tides containing more than one lysine modification, an addi-
tional R script (http://www.R-project.org/), referred to as
StoichiolyzeR (https://github.com/GibsonLab/StoichiolyzeR),
was written in-house and uses the package mzR [53] to extract
fragment ion signal from the mzXML file and to compute the
stoichiometry of acylation sites. Briefly, the StoichiolyzeR
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program requires an mzXML file generated from the original
wiff raw data file, a text file containing the SWATH isolation
window definitions, and a text file containing peptide informa-
tion, such as a Skyline report. The peptide information text file
contains the peptides sequence, peak retention time borders for
peak area extraction/integration, precursor charge, mzXML file
name, and the peptide sequence residue numbers to define the
K-acyl sites within the protein. The program first determines all
theoretical heavy and light fragment ionm/z values that contain
the lysine residue(s). The program also confirms that the
heavy/light precursor ion pairs were sampled in the same
SWATH isolation window. Next, the heavy and light frag-
ment peak areas are extracted using a predefined ppm mass
tolerance within the given retention time elution range.
Fragment ion peak areas subsequently were filtered by a
user-defined minimum heavy peak area to avoid reporting
very noisy, low abundant ions; however, if heavy peak
areas are below the set threshold, the same threshold is
tested for the corresponding light fragment ion (in case a
specific K-acyl site shows a very high stoichiometry in
which case heavy peak areas could be very low). Fragment
ions are further processed if either the heavy or the light
peak area is above the threshold. The ratios of light/(light +
heavy) are computed, and both the median ratio and the
ratio from the highest ranked (differentiating) fragment ion
(rank 1) are reported. The stoichiometry for peptides
containing two lysine residues per peptide is computed
for the first and second lysine using the differentiating
b-ion and y-ion ratios, respectively.
Data Accession
The supplementary files provide further insights into the
SWATH stoichiometry workflows, and advantages of using
SWATH acquisitions to determine acylation occupancy. All
raw files are uploaded at to the Center for Computational Mass
Spectrometry, MassIVE (massive.ucsd.edu), and can be
accessed using the MassIVE ID number: MSV000079779
(ProteomeXchange Accession PXD004234).
Results and Discussions
Acetyl and Succinyl Stoichiometry Workflows
Our modified approach to determine acetylation stoichiometry
was based on the method originally described by Baeza et al.
[15], which depends on the accurate determination of isotopic
peptide isoforms generated in vivo (endogenous) and in vitro
(exogenous), the latter by per-acetylation of proteins with
deuterated acetic anhydride-d6, followed by LC/MS and data
analysis (Figure 1). Compared to their method, we altered
several sample preparation steps. First, we increased the con-
centration of heavy acetic anhydride 3-fold to increase the
chemical acylation efficiency for all three chemical per-
acetylation reactions. Second, after the final acylation reaction,
proteins were treated with hydroxylamine to more completely
reverse O-acylation side reactions [39, 54]. Third, we digested
the per-acetylated proteins with endoproteinase Glu-C instead
of trypsin. Trypsin cannot cleave at C-terminal acylated lysine
residues, and thus tryptic digestions of per-acylated proteins
typically generate peptides that are very large and often contain
many acetylated lysine residues, complicating analysis. Glu-C,
however, is specific for C-terminal cleavage at glutamic and
aspartic acid residues, and the cleavage pattern or efficiency of
Glu-C should not be impacted by the presence of lysine acyl-
ation. In addition, we observed that peptides from Glu-C di-
gestion are more likely to produce both b- and y-ion series due
to the lack of a C-terminal basic residue, offering more flexi-
bility during data analysis when choosing fragment ions that
contain the acetyllysine for quantification. Therefore, we find
that Glu-C digestion is preferable to trypsin digestion for per-
acylated proteins. Finally, we have extended the lysine acety-
lation occupancy method to also allow measurements of
succinylation occupancy (Figure 1b) by substituting the
acylation reagent acetic anhydride-d6 with cyclic succinic
anhydride-d4.
We also implemented two key post-digestion steps that
differ from previous methods in order to further reduce quan-
tification interferences compared with previous methods: pep-
tide fractionation by offline basic pH reversed phase separation
and quantification from fragment ions produced by SWATH
acquisitions. Our SWATHmethodmeasures both the precursor
peptide ion abundances and the fragment ion abundances. To
quantify site occupancy, Skyline was used to extract peak areas
from the fragment ions that contain the acylation site in ques-
tion, hereafter referred to as ‘differentiating fragment ions’
(Figure 1c). Fragment ions that do not contain the modification
have the same light and heavy m/z value and can be used for
peptide identification but not for quantification. Typically,
several differentiating y- and/or b-ions are measured that can
be used for occupancy calculations, which provides flexibility
if MS2-interferences were detected.
SWATH MS2-Based Occupancy Workflow
Assessment Using BSA Standards
As a proof of principle demonstration of our modified DIA-
based stoichiometry approach, we performed several experi-
ments using commercially available acetylated and unmodified
BSA. First, unmodified BSA was processed for stoichiometry
assessments as shown in Figure 1. The efficiency of the chem-
ical reaction was assessed by monitoring the disappearance of
the unmodified species and the appearance of the correspond-
ing N-acetylated species (N-acetyl-lysine). A potential by-
product, the O-acetylated species, was barely detected at very
low levels (~0.25% of N-acetylated main reaction product,
Supplementary Figure S1), confirming the high specificity of
the chemical per-acetylation reaction. Acetylated peptides
identified by database searches were imported into Skyline
with fragment ions ranked by the observed MS/MS spectra
present in Skyline spectral libraries (Figure 2a and Supplemen-
tary Figure S2a). SWATH data was then imported into Skyline
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to extract precursor and fragment ion signals from the light and
heavy acetyl-peptide pairs as shown in Figure 2b to quantify
acylation occupancy. We typically use the highest ranked
differentiating fragment ion per peptide based on spectral li-
brary ranking, and/or the second highest ranked differentiating
fragment ion for occupancy calculations, as higher ranked ions
typically have better ion statistics and less noise or interfer-
ences. This point is illustrated in Supplementary Figure S2b
showing occupancy measurements for unmodified BSA,
which is expected to have very low endogenous modification,
where the L/(L + H) ratios were calculated for 18 peptides
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Figure 1. Stoichiometry workflow. (a) First, protein lysates were incubated three times with acetic anhydride-d6 to acetylate
unmodified lysine residues. Second, samples were digested with endoproteinase Glu-C, followed by optional offline fractionation of
the proteolytic peptides by basic reversed-phase chromatography. Finally, peptides were analyzed by LC-MS in SWATH acquisition
mode. (b) To determine succinylation stoichiometry the same workflow was used as described in (a), except the heavy acylation
reagent was changed to using succinic anhydride-d4. (c) Simulation of data obtained and stoichiometry calculations. Light and
heavy precursor ions containing one acetylated lysine differ by 3 mass units. XICs were generated for both light and heavy isotopic
envelopes indicated in red and blue, respectively (left panels). Similarly, quantification from fragment ion XICs from SWATH
acquisitions can be performed using differentiating light and heavy fragment ions that contain the acetylation site indicated in red
and blue (right panels). Common fragment ions are displayed in black and do not contain the site of modification
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ions per peptide, sorted by their MS/MS library rank; stoichi-
ometry values calculated from fragment ions of ranks 1 and 2
are lower and more accurate compared with values calculated
using less abundant fragment ions.
Corresponding calculations were also performed for the
MS1 precursor ions sorted by their isotope distribution rank
(Supplementary Figure S2b). It is immediately evident that
even when analyzing a single, purified protein, MS1-based
occupancy calculations (Supplementary Figure S2b-left panel)
were incorrect, whereas the fragment ion-based calculations
(Supplementary Figure S2b-right panel) were more accurate,
showing acetylation occupancy values around 1% or less for
endogenous, unmodified BSA (Supplementary Table S3a–d).
A 95%CI) for MS2-based acetyl occupancy was determined to
be between 0.54% and 1.29% with a mean of 0.82%. Addi-
tional measurements for commercially acetylated BSA sample
are listed in Supplementary Table S3. All measurements were
performed in three technical MS injection replicates, and tech-
nical reproducibility for occupancy per each of the peptides
was robust with standard deviations between 0.03% and 0.76%
using our new SWATH MS2-based quantification (see
Supplementary Table S3).
After initially using manual annotation to indicate highest
ranked differentiating fragment ions per K-acyl L/H peptide
pair, we constructed a Python script to automatically determine
the differentiating ions to use for occupancy calculations (see
Methods and Supplementary Table S3). Overall, these proofs-
of-principle experiments using acylated BSA standards
showed that SWATH-MS2 based quantification of acylation
occupancy provided accurate and precise measurements for
both low and higher stoichiometries. These experiments also
revealed that it is best to use rank 1 fragment ions for quanti-
fication as they typically show the best ion statistics and least
interferences.
The methodology was extended to a l low for
succinylation stoichiometry determination by substituting
succinic anhydride-d4 as the acylation reagent. We first
validated the accuracy of this method using BSA to prepare
defined levels of 1%, 10%, 50%, and 100% light
succinylated BSA. Figure 2c shows SWATH MS2-based
occupancy measurements of 18 BSA peptides at each of the
predefined light succinylation levels. The measured occu-
pancy readings matched the predefined levels very well
(Figure 2c and Supplementary Table S3e). We measured
succinylation occupancies for the predefined mixtures of
0%, 1%, 10%, 50%, and 100% light succinylation as
0.8%, 2.0%, 12.6%, 50.1%, and 97.3% with good precision
(standard deviations were 1.0%, 1.0%, 2.6%, 2.5%, and
2.8%, respectively). These results are in accordance with
the isotopic purity of the succinic anhydride-d4, which is
reported at >98%. The isotopic purity for the acetic
anhydride-d6 is reported at 99%. Incomplete isotopic en-
richment of the labeling reagents will lead to a small over-
estimation of 2% (succinyl) or 1% (acetyl) of the endoge-
nous acylation level; thus the determined occupancy levels
are upper limit values.
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Figure 2. Assessing BSA acylation stoichiometry. (a) MS/MS
spectrum for acetylated BSA peptide TYVPKacAFDE displayed
for the light precursor ion at 1110.54 Da with m/z 556.27.
Differentiating ions are indicated in red in the fragmentation
schematic (see inset). (b) Fragment ion XICs for light and heavy
precursor ions atm/z 556.27 andm/z 557.78, respectively. The
differentiating y6 ion is used for occupancy calculations. (c) Site
occupancy for 18 succinylated BSA peptides were determined
from the highest ranked differentiating fragment ions for five
different BSA samples at defined percentages of light modifi-
cation (e.g., at 0%, 1%, 10%, 50%, and 100%)
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Acylation Stoichiometry in Complex E. coli Whole
Lysate
After validation of our stoichiometry quantification workflow
with BSA standards, we applied the method to an E. coliwhole
protein lysate as shown in Figure 1. For this pilot experiment,
we required that the lysine acylation site was previously iden-
tified independently by an anti-acyl enrichment analysis from
Glu-C digestions (Supplementary Table S1a–c). Using this
stringent set of confirmed acetylated peptides, we were able
to manually inspect the peak areas in Skyline providing further
validation of the method. Figure 3 shows example quantifica-
tion of two E. coli acetylation sites, one with relatively high
stoichiometry, and the other low. Specifically, Figure 3 shows
how light/heavy differentiating fragment ions can be chosen for
quantitative processing, and how the XICs appear in Skyline
after fragment ion extraction. Acetylation site occupancy for
K-105 of glucose-specific phosphotransferase enzyme IIA
component (PTGA) was calculated from the fragment ion peak
area ratio (Figure 3a) using the highest ranked differentiating
ion, y5. While the heavy y5 ion signal was above 40,000 counts,
the light version of the y5 ion was observed near baseline levels,
yielding an estimated K-105 acetylation occupancy of only
0.5%. In comparison, a relatively high acetylation site occu-
pancy of ~5% for K-25 of leucine-responsive regulatory pro-
tein (LRP) was determined using the y9 fragment ion peak areas
(Figure 3b), which may be biologically relevant. Supplemen-
tary Table S4 shows an overview of many acetylation sites
investigated for occupancy and, indeed, many lysine acetyla-
tion sites showed occupancy <1% when processing the
SWATH data on the MS-based fragment ion level.
Another example of a relatively high level acetylation stoichi-
ometry is shown in Supplementary Figure S3a for K-100 of 2,3-
bisphosphoglycerate-dependent phosphoglycerate mutase
(GPMA), which is further detailed in Supplementary Table S5.
We previously showed GPMA acetyllysine site K-100 to be
sensitive to acetyl phosphate [22] and glucose supplementation
[23]. Indeed, with glucose added to the growth media, a 33-fold
increase in lysine acetylation was previously determined com-
pared with growth in media without glucose. Using our SWATH
stoichiometry quantificationmethod, we obtained a similar result,
revealing 9.2% acetyl occupancy in bacteria grown with glucose
versus 0.4% occupancy when those same bacteria were grown
without glucose (~23-fold increase, Supplementary Table S5).
For additional confirmation as well as demonstrate the use




































Figure 3. Lysine acetylation site occupancy examples from E. coli whole cell lysate. (a) A low stoichiometry of 0.5% was
determined for acetylated peptide GFKacRIAE representing K-105 in protein PTGA (P69783). The MS/MS is shown for the doubly
charged light precursor ion atm/z 431.74. Fragment ion XICs derived from the corresponding light and heavy precursor ions atm/z
431.74 and m/z 433.25 are shown below. The differentiating y5 ion was used for occupancy calculations. (b) An example for a 5%
stoichiometry was determined from acetylated peptide LQKacDGRISNVE for K-25 of protein LRP (P0ACJ0). The MS/MS for the
light, doubly charged precursor ion at m/z 650.85 is shown, as well as fragment ion XICs for the corresponding light and heavy
precursor ions atm/z 650.85 and m/z 652.36. The differentiating y9 ion was used for occupancy calculations
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we determined occupancy levels using PRM), as described in a
recent paper [46]. Using PRM acquisition, all MS2 fragment
ions, including common fragment ions of the same mass, can
be used for stoichiometry calculations, as their separate precur-
sor ions are isolated at unit resolution (Supplementary
Table S5). Fragment ion peak areas from PRM experiments
of the peptide containing GPMA K-100 reveal low acetyl
occupancy of ~0.2% when bacteria were grown without glu-
cose (Supplementary Figure S3d). However, when E. coli
growth media was supplemented with glucose, occupancies
of 9.6% were determined for this site (Supplementary
Figure S3c), which is essentially the same value obtained by
SWATH (Supplementary Table S5). This measured change in
acetyl stoichiometry represents a 48-fold increase in acetylation
at this GPMA site K-100 upon growth with added glucose,
which is similar to the 33-fold increase we previously deter-
mined using label-free quantification from the lysine acetyla-
tion enrichment workflow. After the initial untargeted SWATH
analysis, such targeted PRM experiments could be implement-
ed as quantitative, high-throughput assays to process many
different samples and conditions.
A relatively high occupancy of 9% for GPMA at K-100 is of
special functional interest as this lysine is located in the binding
site for the enzyme’s substrate, 2-phospho-D-glycerate (Sup-
plementary Figure S3b). Three independent biological repli-
cates of E. coli grown with high glucose were prepared and
processed, and Supplementary Figure S4a shows a selected
subset of sites for which acetylation occupancy was calculated
for acetylation sites from proteins ClpB, DnaK, and LRP using
this new SWATH MS2 quantification method (a more com-
plete table of sites is provided as Supplementary Table S4).
Reproducibility between biological replicates was good for
both low and high stoichiometries, indicating a robust
workflow. For example, lysine acetylation occupancy at K-25
of LRP protein in three biological replicates was measured as
5.5%, 4.6%, and 4.6%.
As described for BSA validation experiments, another
benefit from using SWATH analysis is that we can directly
compare occupancy calculations using MS1 scans acquired
as part of each SWATH cycle with the MS2-based fragment
ion calculations. In some cases, MS1- and MS2-based cal-
culations yielded very similar results for many sites; how-
ever, the MS1-based results showed higher, and likely in-
flated, estimates of occupancy compared with those based
on MS2 ion intensities (Supplementary Table S4). MS1-
based occupancy calculations also showed more variation
among biological replicates, especially when they differed
from the SWATH MS2-based fragment ion results (Supple-
mentary Figure S4b). Lack of precision and accuracy ob-
served from MS1-based calculations is likely caused by
incorrect MS1 measurements due to random interferences
and/or noise. While MS1 measurements can yield acceptable
results for strong signals with little or no interferences, in
this study, the moderate complexity of the E. coli proteome
made the MS1 signals prone to interferences. Stoichiometry
determinations based on MS2 signals are less prone to
interferences, as the MS2 space is less crowded, particularly
when using variable window SWATH acquisitions. In addi-
tion, because multiple fragment ions are measured for each
peptide, interferences can more easily be detected as outliers
in disagreement with other fragments, allowing for selection
of only the most robust fragment ions for quantification.
Figure 4 shows some obvious MS1 interferences in the light,
endogenous channel for acetylated or succinylated peptides,
whereas MS2 fragment ions allowed interference-free quan-
tification. Overall, MS2-based fragment ion measurements
for occupancy appear more reliable and show relatively low
stoichiometry measurements for both acetylated and
succinylated peptides (Supplementary Tables S4 and S6).
In parallel to the acetylation occupancy experiments in
E. coli, experiments using our new succinylation workflow
were applied to wild type E. coli bacteria grown under
conditions similar to those use for the acetylation studies.
Similar to lysine acetylation, the majority of lysine
succinylation modifications in wild type E.coli proteins
showed less than 2% occupancy (Supplementary Table S6).
That said, we anticipate that there are conditions where
lysine succinylation occupancies will be elevated as ob-
served for glucose-induced acetylation occupancy. For ex-
ample, it is expected that any condition that elevates
succinyl-CoA levels should yield increased succinyllysine
stoichiometries. A similar scenario is possible in mutants
deleted for the gene that encodes the Sir2 homolog, CobB,
which has been shown to exhibit both deacetylase and
desuccinylase activities [17, 21, 34].
In an effort to improve accuracy of MS1 measurements,
some of the previously reported stoichiometry determina-
tions attempted to reduce complexity of the samples by
offline fractionation. Here, we used our E. coli succinylation
site occupancy experiments to illustrate interference reduc-
tion afforded by both the use of SWATH-generated frag-
ment ions for quantification and peptide pre-fractionation by
offline bRP (Supplementary Figure S6). Some examples for
succinylation occupancy that clearly showed the reduction
of interferences upon fractionation are displayed in Supple-
mentary Table S6 and Supplementary Figure S5. The mean
succinyl occupancy measured only from precursor signal in
unfractionated sample was 5.4% ± 9.6% (Supplementary
Figure S6). Using fragment ion signal from the same acqui-
sitions to calculate occupancy, however, resulted in an av-
erage of 3.0% ± 5.5%, which clearly demonstrates how
possible MS1 interferences can inflate reported occupancy.
Furthermore, the reduction of interferences due to fraction-
ation is evident both in the MS1- and MS2-measured succi-
nyl occupancies; the average occupancy measured by MS1
in the bRP fractionated samples was 1.5% ± 4.9%, and the
average occupancy measured by MS2 in the bRP fractionat-
ed samples was 0.7% ± 0.9% (Supplementary Figure S6).
The improvements in quantification from fractionated sam-
ples appear to result from both the reduction of sample
complexity and the ability to load more sample; thus, pep-
tide fractionation increases signal and reduces complexity.
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Peptides containing multiple lysines present an additional
challenge when determining acylation occupancy, which our
fragment ion-based quantification strategy is uniquely well-
suited to determine. An example of stoichiometry determi-
nation for a peptide containing two acetylated lysine resi-
dues from ribosomal protein RL11 is shown in Figure 5.
Skyline allows for synchronized quantification of any com-
bination of light and heavy acetylated lysine residues, i.e., an
unlabeled peptide (light/light), singly-labeled mixed species
(light/heavy and heavy/light), and the doubly-labeled ver-
sion (heavy/heavy). Although the precursor ion signal does
reflect the total level endogenous acetylation for the singly-
labeled mixed peptide (Figure 5a), endogenous acylation at
the first lysine cannot be differentiated from the endogenous
acylation at the second lysine. However, using differentiat-
ing fragment ions it is possible to determine endogenous
acetylation levels for each lysine site independently
(Figure 5b). In this specific example, the b7 ion, which
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(b) MS1 interferences for VVAVSKacLGDIE 















Figure 4. Demonstration of MS1 interferences. (a) Precursor and fragment ion chromatograms were extracted from light/heavy
precursor ions pairs atm/z 521.30 andm/z 522.80 for the acetylated peptideKacIVIANRGE containing K-4 in ACCC protein. Strong
interferences in the light MS1 signal that did not co-elute with the extracted fragment ions led to an overestimatedMS1-based lysine
acetylation occupancy 14.3%. The fragment ion XICs, specifically from the differentiating b3 ion, indicated an acetylation occupancy
of 0.6%. (b) Precursor and fragment ion chromatogramswere extracted from light/heavy precursor ions pairs atm/z 586.33 andm/z
587.84 for the acetylated peptide VVAVSKacLGDIE containing K-48 in GRCA protein. Strong interferences in the light MS1 signal
that clearly did not co-elute with other ions led to an overestimated MS1-based lysine acetylation occupancy of 39.1%. The
fragment ion XICs, specifically from the differentiating b9 ion, indicated an acetylation occupancy of 3.2%
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contains only the first acetylation site, has strong light
(endogenous) signal (m/z 881.4), whereas the corresponding
heavy transition (m/z 884.4) is much weaker. These results
indicated that the high level of endogenous acetylation ob-
served was on the first lysine (K-40) with a high stoichiom-
etry of 92.3%. Supplementary Figure S7a demonstrates how
to set up the Skyline document for peptides containing two
Kac residues. In addition, we have developed an in-house
algorithm, the StoichiolyzeR, to automate the determination
of acylation site stoichiometries from peptides with multiple
lysines. Supplementary Figure S7b indicates specific details
and considerations regarding stoichiometry calculations for
‘double Kac’ peptides.
Conclusions
In this study, we present a novel method to quantify site-
specific acetylation and succinylation occupancy that can be
applied to an entire proteome. Similar to previous methods, our
strategy is based on chemical acylation of all unmodified
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(b) MS2 of FCKacAFNAKacTDSIE 
Figure 5. Stoichiometry calculation for peptides containing two Lysine residues. (a) Skyline target tree can be populated with all
possible light (L) and heavy (H) acetyl permutations for peptide FCKacAFNAKacTDSIE from ribosomal RL11 protein atm/z 807.88
(LL),m/z 810.90 (HH), and the mixed species atm/z 809.29 (LH and HL). Precursor ion XICs are shown for all four species, although
the mixed species LH and HL cannot be differentiated using precursor m/z alone. (b) Fragment ion XICs can differentiate the
occupancy for both lysine acetylation sites. Fragment ion b7, which contains only the first lysine residue, K-40, was used to
determine a stoichiometry of 92.3%. The b8 ion, containing both lysines, was used to calculate a low stoichiometry of 1.6% for
the second lysine site, K-45, present in this peptide
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due to the use of more comprehensive SWATH acquisition.
We demonstrate how signal interferences, particularly in MS1
scans, can lead to overestimation of site occupancies. More
importantly, we show that interferences can be decreased by
using a SWATH-MS2-based quantification strategy. Even
when interferences were present in some MS2 scans, access
to comprehensive MS2 data from SWATH acquisitions allows
selection of a different fragment ion from the same peptide that
would also differentiate the light and heavy peptide forms, and
stoichiometries can still be determined. However, precursor ion
interferences can rarely be corrected in post-acquisition
analysis.
Precursor interferences may become less of an issue for next
generation high-resolution instruments generating exceedingly
high MS1 resolution; however, there are additional advantages
unique to fragment ion quantification from SWATH acquisi-
tions. First, when using precursor ion quantification only, it is
not possible to determine stoichiometry for peptides containing
multiple lysine residues; using fragment ion quantification
from SWATH data, we can measure stoichiometry for peptides
containing up to three different lysines with our novel algo-
rithm StoichiolyzeR. Second, SWATH data containing full
scan MS and MS/MS information significantly improves con-
fidence in peak assignment during data processing. Third,
SWATH data collection and analysis using the combination
of Skyline and our StoichiolyzeR package can be applied to
any similar stable isotope-based workflow that traditionally
uses precursor signal quantification to improve quantification
accuracy, such as SILAC or dimethyl labeling. Finally, this
type of fragment-specific quantification can be applied to new
areas such as PTM localization.
In addition to the advantages of using SWATH as discussed
above, we found that fractionation of peptides prior to mass
spectrometric analysis greatly improves our measurements,
especially for complex samples. Most of the lysine-
acetylation and lysine-succinylation stoichiometries measured
from E. coli proteins using our SWATH-MS2 methodology
were relatively low (<5%). We determined acetylation occu-
pancies between 0% and 2% for 84% of the monitored sites,
occupancies between 2% and 5% for 12% of the sites, occu-
pancies between 5% and 10% for 3% of the sites, and we
observed only 1% of sites with occupancies >10% (Supple-
mentary Figure S8), for our given experimental conditions.
Stoichiometry assessments may guide researchers towards
these acylation hotspots and possibly provide valuable infor-
mation for which acylation sites to invest in biological follow-
up experiments, for example, site-directed mutagenesis of the
acylation site. In addition, we outlined interesting mass spec-
trometric follow-up workflows that can be performed, such as
PRM-MS. For example, after an initial global SWATH analy-
sis, highly multiplexed, targeted PRM-MS acquisitions [46] of
most interesting targets (i.e., high site occupancy) could be
implemented as high throughput, quantitative assay to process
many different samples and conditions.
We believe it is important to determine occupancy for
multiple forms of acylation, as it has been shown that many
succinylation sites overlap extensively with acetylation [11,
55]. An assumption of previous acetylation stoichiometry stud-
ies was that each measured peptide is only modified by acety-
lation, which we know from several studies does not have to be
a true. Even in this study, we are likely overestimating site
occupancy (slightly) because of other unaccounted lysine mod-
ifications at the same site, such as ubiquitination and methyla-
tion. However, by extending the method to also measure
succinylation stoichiometry, we raise the possibility of using
several per-acylation methods in parallel to get more accurate
readings of actual endogenous site occupancy among several
modifications.
Several aspects of our unique data analysis pipeline facili-
tate this new workflow. The use of Skyline’s graphical user
interface for stoichiometry calculation provides an easy way to
assess and confirm quality of measurements. Light and heavy
signals are always integrated together over the same elution
time window (‘integrate all’ feature in Skyline). In addition,
using the DIA-Umpire signal extraction algorithm to generate
pseudo MS/MS spectra allowed us to import SWATH
acquisition-derived identifications from database searches into
Skyline, which then displays a line in the chromatograms
marking the time of identification, referred to as BID line.^
This ensures that the correct peak for occupancy calculation is
selected in all cases because the heavy, non-endogenous signal
is almost always sufficiently abundant to be identified by the
database search. Finally, the StoichiolyzeR package provides
an easy way to calculate the stoichiometry, including from
peptides containing multiple lysine residues.
Overall, we present methods for the determination of acet-
ylation and succinylation stoichiometry that are robust and less
prone to ion interferences than MS1-only measurements. Data
obtained from these protocols should provide more accurate
insights into dynamic acylation effects on proteins under dif-
ferent biological conditions. Even though we find that in our
system most sites have low acylation stoichiometries, these
modifications may still play a very significant functional role
in modulating pathways and networks. For example, low-level
lysine acylation could exert significant effects on the formation
and/or stability of protein–protein interactions and protein
complexes, especially for metabolic proteins that often form
homo-multimers with cooperative activity. Alternately, these
low-level modifications could have indirect functional effects,
acting as a sink for acyl-CoA during nutrient excess, and by
regulating the pool of NAD+, which is degraded by sirtuin-
coupled deacylation.
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